- $288.68bn
- $313.21bn
- $54.07bn
Nuvectis gains two experimental drugs in licensing deal with China's Haisco
Press Digest: British Business - June 22
Moderna's mRNA flu vaccine backed by FDA advisers (updated)
Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny
Northern Ireland's post-Brexit boost is in peril
Analysis: Big pharma taps UK playbook to pressure European capitals on drug prices
Refile: FACTBOX-UK Market Exodus: Companies that moved away from London listing in recent years
Factbox: Global drugmakers invest billions to boost US presence
Brief: Astrazeneca Says Ultomiris Granted Priority Review In US As Treatment For Adults With Immunoglobulin A Nephropathy
Brief: AstraZeneca Says Truqap Approved In US For Prostate Cancer
Truqap approved in US for prostate cancer
Brief: Astrazeneca Says Truqap Combination Approved In US For A Type Of Prostate Cancer
UK Market Exodus: Companies that moved away from London listing in recent years
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Race to launch weight-loss pill heats up as Novo wins UK approval
Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal (updated)
Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal
Focus: Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon
Factbox: What Bundibugyo Ebola vaccines and treatments are under development